Human genes involved in hepatitis B virus infection

World J Gastroenterol. 2014 Jun 28;20(24):7696-706. doi: 10.3748/wjg.v20.i24.7696.

Abstract

Persistent hepatitis B virus (HBV) infection is a significant public health problem because it is a major cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). Roughly one-third of the world population has been infected with HBV and there are about 350 million (5%-6%) persistent carriers. HBV causes 80% of all liver cancer cases and is the second most important carcinogen, after smoking tobacco. There is an approximate 90% risk of becoming a persistent carrier following perinatal infection in infants born to e antigen positive carrier mothers and a 30% risk in pre-school children. Only 5%-10% of adults become persistent carriers following infection. Of individuals persistently infected with HBV, 10%-30% will develop liver cirrhosis and HCC. These highly variable outcomes in both clearance rates and disease outcomes in persistently infected individuals cannot be fully explained by differences in immunological, viral or environmental factors. Thus, differences in host genetic factors may affect the natural history of hepatitis B.

Keywords: Clearance; Epidemiology; Genetic; Hepatitis B virus; Hepatocellular carcinoma; Natural history; Outcome; Persistance; Polymorphism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Genetic Markers
  • Genetic Predisposition to Disease
  • Hepatitis B / genetics*
  • Hepatitis B / virology*
  • Hepatitis B virus / pathogenicity*
  • Host-Pathogen Interactions / genetics
  • Humans
  • Phenotype
  • Prognosis
  • Risk Factors

Substances

  • Genetic Markers